OMX30 1 577 0,2%  OMXH25 4 141 0,1%  Bitcoin 9 395,03 -3,2%  Dow 25 310 1,4%  Nas 6 897 2,0%  EUR 10,0489 0,4%  USD 8,1733 0,0%  Olja 67,1 1,4%  Guld 1 329 -0,2% 

Johnson & Johnson Aktie

132,08USD 2,15USD 1,65%
<
Bolag
Terminer
Profil
>
<
Relaterade värdepapper
Obligationer
>

Johnson & Johnson Chart - 1 År - BTT

Fundamentala nyckeltal för Johnson & Johnson

2017 2018e 2019e 2020e 2021e
Utdelning 3,32 3,60 3,82 4,10 -
Direktavkastning (i %) 2,34 2,74 2,91 3,12 2,76
PE-tal 19,40 16,23 15,40 14,38 13,64
Resultat/aktie 7,30 8,10 8,53 9,14 9,64
ytterligare nyheter

Analyser om Johnson & Johnson

ytterligare analyser

Johnson & Johnson Peer Group

Abbott Laboratories 59,71
1,2%
Alexion Pharmaceuticals 118,91
3,7%
Allergan 0,00
0,0%
AstraZeneca 549,80
0,1%
Bayer 97,92
-0,5%
Beiersdorf 91,88
1,8%
Celgene 95,62
2,0%
DOUGLAS 0,00
0,0%
Fresenius Medical Care 87,94
0,3%
Fresenius 63,48
-0,3%
GlaxoSmithKline 12,96
-0,5%
Johnson & Johnson 132,08
1,7%
Merck 54,89
0,6%
Merck 82,34
0,0%
MorphoSys 75,55
0,7%
Nestlé 75,76
0,2%
Novartis 79,38
-0,8%
Pfizer 36,28
1,5%
Procter & Gamble 81,07
0,3%
Roche 225,80
-0,3%
STADA 86,30
0,0%
Sanofi 65,05
0,2%
Unilever 43,49
0,8%
pagehit

Lägg till instrument

Vad tycker du?

Profil Johnson & Johnsontill bolagsprofilen

Johnson & Johnson is an investment holding company with interests in health care products. It engages in research and development, manufacture and sale of personal care hygienic products, pharmaceuticals and surgical equipment. The company operates through the following business segments: Consumer, Pharmaceutical and Medical Devices. The Consumer segment includes products used in the baby care, skin care, oral care, wound care and women's health care fields, as well as nutritional and over-the-counter pharmaceutical products, and wellness and prevention platforms. Its baby care franchise includes the JOHNSON'S Baby line of products. The Pharmaceutical segment includes products in the anti-infective, antipsychotic, contraceptive, gastrointestinal, hematology, immunology, infectious diseases, neurology, oncology, pain management, thrombosis and vaccines. The Medical Devices segment includes products distributed to wholesalers, hospitals and retailers, used principally in the professional fields by physicians, nurses, hospitals, and clinics. It include products to treat cardiovascular disease; orthopaedic and neurological products; blood glucose monitoring and insulin delivery products; general surgery, biosurgical, and energy products; professional diagnostic products; infection prevention products; and disposable contact lenses. Johnson & Johnson was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.

Realtidskurs Johnson & Johnson

Bid 131,33 USD Ask 151,10 USD
Kurstid 21:59 Börsen BTT

Aktiekurs Johnson & Johnson i USDPUSH CHART

Kurs 132,08 USD 2,15 1,65 %
Kurstid 21:59:59
Datum 23.02.2018
Öppning 130,36
Gårdagen 129,93
Dagshögsta 132,08
Dagslägsta 130,05
52 v. högsta 149,30
52 v. lägsta 119,50
52 v. perf.
Volym (Antal) 288 390
Börsvärde (SEK) 2 866,68 Mrd
Börsen
Kurs för 132,08 USD från börsen BATS Trading motsvarar med aktuell växelkurssentspricht USD/SEK en kurs på 1 079,53 SEK.

Till aktien Johnson & Johnson

Ticker
ISIN US4781601046
Index NYSE US 100, BX Swiss - USA, Dow Jones, S&P 500, S&P 100

Johnson & Johnson Nyckeltal

Börsvärde i SEK 2 866,68 Mrd
Free float % 99,89
Antal aktier mio. 2 682,90
Cashflow/aktie i lokal valuta 2,66
Bokvärde/aktie i lokal valuta 22,62
60 dagar vola 22,77
PBV 6,26

Johnson & Johnson Historiska kurser

2018-02-22 129,93 376 052
2018-02-21 129,88 308 779
2018-02-20 130,83 352 554
2018-02-16 133,15 616 708
2018-02-15 131,27 292 057

Aktier i samma industri med bättre 1 års perf.

Nektar Therapeutics 491,5 %
Sangamo Therapeutics Inc 403,2 %
Amylin Pharmaceuticals Inc. 264,9 %
ImmunoGen Inc. 260,8 %
Ariad Pharmaceuticals Inc. 260,2 %